Anvisa authorization for electronic prescriptions of controlled substances: implications for equity in access to pain management in Brazil
Guilherme Antonio Moreira de Barros et al · Escola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz · 2026
Acceso al recurso
Entrá al contenido desde la opción principal o elegí otra fuente disponible.
Acceso abierto al texto completo
Cómo citar
Elegí el formato que necesitás y copiá la referencia al portapapeles.
APA 7
al, G. A. M. D. B. E. (2026). Anvisa authorization for electronic prescriptions of controlled substances: implications for equity in access to pain management in Brazil. https://doi.org/10.1590/0102-311xen266325
MLA
al, Guilherme Antonio Moreira de Barros et. "Anvisa authorization for electronic prescriptions of controlled substances: implications for equity in access to pain management in Brazil." 2026. https://doi.org/10.1590/0102-311xen266325.
Chicago
al, Guilherme Antonio Moreira de Barros et. 2026. "Anvisa authorization for electronic prescriptions of controlled substances: implications for equity in access to pain management in Brazil.". https://doi.org/10.1590/0102-311xen266325.
Harvard
al, G. A. M. D. B. E. 2026, Anvisa authorization for electronic prescriptions of controlled substances: implications for equity in access to pain management in Brazil, Escola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz, available at: https://doi.org/10.1590/0102-311xen266325 [Accessed 1 Jul. 2026].
Detalles del recurso
Información bibliográfica útil para confirmar que se trata del material correcto.
- Título
- Anvisa authorization for electronic prescriptions of controlled substances: implications for equity in access to pain management in Brazil
- Autor / colaboradores
- Guilherme Antonio Moreira de Barros et al
- Editorial
- Escola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz
- Año de publicación
- 2026
- ISSN
- 1678-4464
- ISSN
- 1678-4464
- Idioma
- eng